Matthew Hill

Matthew Hill

Former Chief Financial OfficeratPDS Biotechnology· In proxies 2022–2023

Pay in FY2023+321% from the year before · PDS Biotechnology stock -62.3% the same year

Matthew Hill was paid $2.1M in FY2023 (Dec), up 321%. PDS Biotechnology stock fell 62.3% that year.

Pay$100 in the stock at the end of FY21 → $61
Pay is from the Summary Compensation Table of each PDS Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PDS BiotechnologyPublic company · 4 yr
    • Former Chief Financial Officer2022 – Present · 4 yrStock in role -82%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?